ACRS CIK: 1557746

Aclaris Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.05
FY22:
25.7
FY23:
27.8
FY24:
15.9
FY25:
5.74
(positive)
Change from FY21 to FY25
millions USD
FY21:
−89.7
FY22:
−89.9
FY23:
−97.4
FY24:
−142
FY25:
−76.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−90.9
FY22:
−86.9
FY23:
−88.8
FY24:
−132
FY25:
−64.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−90.9
FY22:
−86.9
FY23:
−88.5
FY24:
−132
FY25:
−64.9

All amounts in millions USD Data source:SEC EDGAR